TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/1/23 16:41 | 2/28/23 | INBX | Inhibrx, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | S | -2 | 25.02 | 0 | 0 | 0 | 3,046 | I | ||||||||||||||
1/24/23 18:46 | 1/23/23 | INBX | Inhibrx, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | S.m | -661 | 25.42 | 0 | -26 | -1 | 3,046 | I | ||||||||||||||
12/20/22 16:59 | 12/19/22 | INBX | Inhibrx, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | S | -664 | 25.56 | 0 | -26 | -1 | 3,072 | I | ||||||||||||||
11/18/22 17:06 | 11/17/22 | INBX | Inhibrx, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | S | -725 | 27.88 | 0 | -26 | -1 | 3,098 | I | ||||||||||||||
10/18/22 16:37 | 10/17/22 | INBX | Inhibrx, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | S | -769 | 29.59 | 0 | -26 | -1 | 3,124 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |